由于细胞免疫学和DNA 重组技术二个领域的快速发展人类癌的有效免疫治疗有了新的可能性。鉴于细胞免疫系统在组织排斥中的重要地位、淋巴因子在免疫调节中的作用、MHC 约束和非约束性细胞溶解的特征和淋巴因子及生长因子的分离,遗传修饰、表达和纯化使得人们有更多可选择的途径去刺激带瘤宿主的抗肿瘤免疫反应。 Due to the rapid development of two areas of cellular immunology and DNA recombination technologies, there is a new possibility of effective immunotherapy for human cancers. Given the importance of the cellular immune system in tissue rejection, the role of lymphokines in immune regulation, the characteristics of MHC restriction and non-binding cell lysis, and the separation of lymphokines and growth factors, genetic modification, expression, and purification make people more There are many alternative ways to stimulate the tumor-bearing host’s anti-tumor immune response.